致病性弧菌属对诺氟沙星及其他六种抗菌剂的体外敏感性
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
作者信息
Morris J G, Tenney J H, Drusano G L
出版信息
Antimicrob Agents Chemother. 1985 Sep;28(3):442-5. doi: 10.1128/AAC.28.3.442.
Abstract
The in vitro activity of norfloxacin and six other antimicrobial agents was tested against 93 vibrio strains representing the currently described pathogenic Vibrio species. Norfloxacin had excellent activity against all species, with the following MICs for 90% of the strains: 0.016 micrograms/ml for Vibrio cholerae (including tetracycline-resistant V. cholerae O1 strains), 0.25 micrograms/ml for V. parahaemolyticus, and 0.063 micrograms/ml for V. vulnificus.
摘要
对诺氟沙星及其他六种抗菌剂的体外活性进行了测试，受试对象为93株代表当前已描述的致病性弧菌物种的弧菌菌株。诺氟沙星对所有物种均具有优异活性，对于90%的菌株，其最低抑菌浓度（MIC）如下：霍乱弧菌为0.016微克/毫升（包括四环素耐药的霍乱弧菌O1菌株），副溶血性弧菌为0.25微克/毫升，创伤弧菌为0.063微克/毫升。
相似文献
1
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.致病性弧菌属对诺氟沙星及其他六种抗菌剂的体外敏感性
Antimicrob Agents Chemother. 1985 Sep;28(3):442-5. doi: 10.1128/AAC.28.3.442.
2
[Sensitivity tests in various potentially pathogenic microorganisms].
Z Gesamte Inn Med. 1972 Jan 1;27(1):41.
3
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.某些抗生素对来自本地治里的霍乱弧菌O139分离株的最低抑菌浓度（MIC）
Epidemiol Infect. 1997 Aug;119(1):25-8. doi: 10.1017/s0950268897007553.
4
Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.霍乱弧菌O139中因多重耐药质粒导致的四环素耐药性出现。
FEMS Immunol Med Microbiol. 1995 Apr;11(2):131-6. doi: 10.1111/j.1574-695X.1995.tb00099.x.
5
In vitro response to chloramphenicol, tetracycline, ampicillin, gentamicin, and beta-lactamase production by halophilic Vibrios from human and environmental sources.来自人类和环境源的嗜盐弧菌对氯霉素、四环素、氨苄青霉素、庆大霉素的体外反应及β-内酰胺酶的产生
Antimicrob Agents Chemother. 1978 Feb;13(2):244-8. doi: 10.1128/AAC.13.2.244.
6
[Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].[革兰氏阴性微生物和支原体在体外对米诺环素的敏感性范围]
Arzneimittelforschung. 1974 Sep;24(9):1256-8.
7
In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.粘质沙雷氏菌医院菌株对化疗药物的体外敏感性
Chemotherapy. 1976;22(1):43-54. doi: 10.1159/000221909.
8
9
In vitro activity of norfloxacin and other antibacterial agents against gastro-intestinal pathogens isolated in Sweden.
APMIS. 1990 Feb;98(2):150-5. doi: 10.1111/j.1699-0463.1990.tb01015.x.
10
Effect of recent antibacterial agents against bacteria causing diarrhoea.
Scand J Infect Dis Suppl. 1988;56:7-10.
引用本文的文献
1
Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in .鉴定和验证靶向 HlyU 调控毒力的抗病毒药物在 …… 中的作用。
Front Cell Infect Microbiol. 2018 May 11;8:152. doi: 10.3389/fcimb.2018.00152. eCollection 2018.
2
Construction of a tetracycline inducible expression vector and characterization of its use in Vibrio cholerae.四环素诱导表达载体的构建及其在霍乱弧菌中的应用特性研究
Plasmid. 2014 Nov;76:87-94. doi: 10.1016/j.plasmid.2014.10.004. Epub 2014 Oct 24.
3
Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.定量 PCR 及抗生素在治疗创伤弧菌感染小鼠模型中的体内疗效。
Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2461-7. doi: 10.1007/s10096-012-1592-z. Epub 2012 Mar 21.
4
Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel.
Emerg Infect Dis. 2008 Dec;14(12):1875-82. doi: 10.3201/eid1412.080499.
5
Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.副溶血性弧菌野生型菌株及其氟喹诺酮抗性突变体的gyrA和parC同源物的序列分析。
Antimicrob Agents Chemother. 1999 May;43(5):1156-62. doi: 10.1128/AAC.43.5.1156.
6
Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.O1群、O139群及非O1群霍乱弧菌的Vitek系统抗菌药物敏感性试验
J Clin Microbiol. 1996 Apr;34(4):897-900. doi: 10.1128/jcm.34.4.897-900.1996.
7
In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan.
Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):151-3. doi: 10.1007/BF02111880.
8
Cholera.霍乱
Clin Microbiol Rev. 1995 Jan;8(1):48-86. doi: 10.1128/CMR.8.1.48.
9
The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Infection. 1986 Nov-Dec;14(6):294-8. doi: 10.1007/BF01643966.
10
Quinolones and the gastrointestinal tract.
Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1093-101. doi: 10.1007/BF01975176.
本文引用的文献
1
Endemic cholera in rural Bangladesh, 1966-1980.1966 - 1980年孟加拉国农村的地方性霍乱
Am J Epidemiol. 1982 Dec;116(6):959-70. doi: 10.1093/oxfordjournals.aje.a113498.
2
Campylobacter enteritis in the United States. A multicenter study.美国弯曲杆菌肠炎：一项多中心研究
Ann Intern Med. 1983 Mar;98(3):360-5. doi: 10.7326/0003-4819-98-3-360.
3
Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh.霍乱弧菌O1血清群、埃尔托生物型的质粒介导多重耐药性：孟加拉国一次点源暴发的证据
J Infect Dis. 1983 Feb;147(2):204-9. doi: 10.1093/infdis/147.2.204.
4
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.环丙沙星对弯曲杆菌属及其他肠道病原菌的体外活性比较
Antimicrob Agents Chemother. 1984 Apr;25(4):504-6. doi: 10.1128/AAC.25.4.504.
5
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.十种抗菌剂对细菌性肠道病原体的体外活性比较
Antimicrob Agents Chemother. 1983 Oct;24(4):509-13. doi: 10.1128/AAC.24.4.509.
6
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.新型吡啶羧酸AT-2266的体外抗菌特性
Antimicrob Agents Chemother. 1983 May;23(5):641-8. doi: 10.1128/AAC.23.5.641.
7
Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers.给人类志愿者单次口服给药后粪便中诺氟沙星的回收率。
Antimicrob Agents Chemother. 1984 Jul;26(1):110-1. doi: 10.1128/AAC.26.1.110.
8
The pharmacokinetics and tissue penetration of norfloxacin.诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.
9
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.诺氟沙星（MK - 0366，AM - 715）及其他药物对胃肠道病原体的体外抗菌活性。
Antimicrob Agents Chemother. 1983 Jan;23(1):86-90. doi: 10.1128/AAC.23.1.86.
10
Optimal antibiotic therapy in cholera.霍乱的最佳抗生素治疗
Bull World Health Organ. 1968;39(2):239-45.
Zotero 插件